Xinxiang Ruicheng Technology Competitors and Similar CompaniesClear all

Xinxiang Ruicheng Technology's competitors and similar companies include Transasia Bio-Medicals, Zhejiang Orient Gene Biotech, Agilent Technologies and Ortho Clinical Diagnostics US.

	Xinxiang Ruicheng Technology Xinxiang Ruicheng Technology (新乡瑞诚科技股份有限公司) is a manufacturer and supplier of pharmaceutical products.	Transasia Bio-Medicals Transasia Bio-Medicals is a developer and manufacturer of healthcare products.	Zhejiang Orient Gene Biotech Zhejiang Orient Gene Biotech (浙江东方基因生物制品股份有限公司) is a company that manufactures and sells vitro diagnostic products,	Agilent Technologies Agilent Technologies is a company that designs and manufactures laboratory instruments.	Ortho Clinical Diagnostics US Ortho Clinical Diagnostics US is a company specializing in in vitro diagnostics.
Founding Date	Founding Date 2015	Founding Date 1979	Founding Date 2005	Founding Date 1999	Founding Date 1994
Type	Type Private	Type Subsidiary	Type Public	Type Public	Type Subsidiary
Tags	Tags Healthcare manufacturing equipment medical devices medical diagnostics	Tags Healthcare medical devices medical diagnostics	Tags Healthcare medical devices medical diagnostics	Tags Healthcare medical devices medical diagnostics	Tags Healthcare medical devices medical diagnostics
Locations	Locations HQ	Locations HQ	Locations Huzhou, CN HQ	Locations Santa Clara, US HQ Victoria, AU Wien, AT Zaventem, BE Barueri, BR Mississauga, CA Beijing, CN see more	Locations Raritan, US HQ Rochester, US
Employees	Employees N/A	Employees 2,0351% increase	Employees 2,231	Employees 18,0001% decrease	Employees 1,650
Valuation ($)	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 945.9 m	Valuation ($) 37.7 b	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) ¥910.7m (FY, 2025)	Revenue (est.) $6.9b (FY, 2025)	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods ¥560.9m (FY, 2025)	Cost of goods $3.3b (FY, 2025)	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit ¥366.6m (FY, 2025)	Gross profit $3.6b (FY, 2025)	Gross profit N/A
Net income	Net income N/A	Net income N/A	Net income (¥597.4m) (FY, 2025)	Net income $1.3b (FY, 2025)	Net income N/A